N-Ethyl-2-[4-[7-[[4-(Ethylsulfonylamino)Cyclohexyl]Methyl]-2,7-Diazaspiro[3.5]Nonan-2-Yl]Pyrimidin-5-Yl]Oxy-5-Fluoro-N-Propan-2-Ylbenzamide

1 trials Orphan designation

Filter these 1 trials by condition, phase, country and more.

1 Registered trials

0 Recruiting

1 Completed trials

1 Sponsors

6 Countries

Phase I (FiH)

Phase I (FiH): 1

Sponsors using this IMP

1 total

Showing 1–1 of 1 trials